Use este identificador para citar ou linkar para este item:
https://observatorio.fm.usp.br/handle/OPI/44208
Título: | Current pharmacotherapy of overactive bladder |
Autor(es): | KREYDIN, Evgenyi I.; GOMES, Cristiano M.; CRUZ, Francisco |
Parte de: | INTERNATIONAL BRAZ J UROL, v.47, n.6, p.1091-1107, 2021 |
Resumo: | Overactive bladder is a symptom complex consisting of bothersome storage urinary symptoms that is highly prevalent among both sexes and has a significant impact on quality of life. Various antimuscarinic agents and the beta-3 agonists mirabegron and vibegron are currently available for the treatment of OAB. Each drug has specific pharmacologic properties, dosing schedule and tolerability profile, making it essential to individualize the medical treatment for the patient's characteristics and expectations. In this manuscript, we review the most important factors involved in the contemporary pharmacological treatment of OAB. |
Aparece nas coleções: | Artigos e Materiais de Revistas Científicas - HC/IOT Artigos e Materiais de Revistas Científicas - LIM/55 |
Arquivos associados a este item:
Arquivo | Descrição | Tamanho | Formato | |
---|---|---|---|---|
art_KREYDIN_Current_pharmacotherapy_of_overactive_bladder_2021.PDF | publishedVersion (English) | 280.52 kB | Adobe PDF | Visualizar/Abrir |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.